M&A Deal Summary |
|
|---|---|
| Date | 2021-02-26 |
| Target | Ajinomoto Animal Nutrition Europe S.A.S. |
| Sector | Consumer Products |
| Buyer(s) | METabolic EXplorer |
| Sellers(s) | Ajinomoto |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Information Technology |
| Employees | 69 |
| Revenue | 170M EUR (2019) |
METabolic EXplorer focuses on the development of new bioprocesses. The company develops and applies cutting-edge biotechnology tools to identify the metabolic pathways of bacteria, yeasts and plants in order to d new fermentation-based biosynthetic pathways for the production of chemicals. METabolic EXplorer was founded in 1999 and is based in Saint-Beauzire, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
Ajinomoto is a manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. Ajinomoto was incorporated in 1909 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 2 |
| Country: France M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-09 |
Ajinomoto Cambrooke
Ayer, Massachusetts, United States Ajinomoto Cambrooke, Inc. is a therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy. |
Buy | $64M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-13 |
Forge Biologics
Grove City, Ohio, United States Forge Biologics is a viral vector and plasmid contract development and manufacturing organization (CDMO) and clinical-stage therapeutics company, enabling access to potentially life-changing gene therapies by bringing them from concept to reality. Forge Biologics was founded in 2020 and is based in Grove City, Ohio. |
Buy | $620M |
